125 related articles for article (PubMed ID: 11896289)
1. Ranking of allergenic potency of rubber chemicals in a modified local lymph node assay.
De Jong WH; Van Och FM; Den Hartog Jager CF; Spiekstra SW; Slob W; Vandebriel RJ; Van Loveren H
Toxicol Sci; 2002 Apr; 66(2):226-32. PubMed ID: 11896289
[TBL] [Abstract][Full Text] [Related]
2. Determination of the sensitising activity of the rubber contact sensitisers TMTD, ZDMC, MBT and DEA in a modified local lymph node assay and the effect of sodium dodecyl sulfate pretreatment on local lymph node responses.
De Jong WH; Tentij M; Spiekstra SW; Vandebriel RJ; Van Loveren H
Toxicology; 2002 Jul; 176(1-2):123-34. PubMed ID: 12062936
[TBL] [Abstract][Full Text] [Related]
3. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S
J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
[TBL] [Abstract][Full Text] [Related]
4. Intralaboratory validation of alternative endpoints in the murine local lymph node assay for the identification of contact allergic potential: primary ear skin irritation and ear-draining lymph node hyperplasia induced by topical chemicals.
Ulrich P; Streich J; Suter W
Arch Toxicol; 2001 Feb; 74(12):733-44. PubMed ID: 11305775
[TBL] [Abstract][Full Text] [Related]
5. Chemical applicability domain of the Local Lymph Node Assay (LLNA) for skin sensitisation potency. Part 2. The biological variability of the murine Local Lymph Node Assay (LLNA) for skin sensitisation.
Roberts DW; Api AM; Aptula AO
Regul Toxicol Pharmacol; 2016 Oct; 80():255-9. PubMed ID: 27470439
[TBL] [Abstract][Full Text] [Related]
6. Use of an ex vivo local lymph node assay to assess contact hypersensitivity potential.
Piccotti JR; Kawabata TT
J Immunotoxicol; 2008 Jul; 5(3):271-7. PubMed ID: 18830887
[TBL] [Abstract][Full Text] [Related]
7. A quantitative method for assessing the sensitizing potency of low molecular weight chemicals using a local lymph node assay: employment of a regression method that includes determination of the uncertainty margins.
van Och FM; Slob W; de Jong WH; Vandebriel RJ; van Loveren H
Toxicology; 2000 Apr; 146(1):49-59. PubMed ID: 10773362
[TBL] [Abstract][Full Text] [Related]
8. The impact of vehicle on the relative potency of skin-sensitizing chemicals in the local lymph node assay.
Jowsey IR; Clapp CJ; Safford B; Gibbons BT; Basketter DA
Cutan Ocul Toxicol; 2008; 27(2):67-75. PubMed ID: 18568891
[TBL] [Abstract][Full Text] [Related]
9. Use of the local lymph node assay for the estimation of relative contact allergenic potency.
Basketter DA; Balikie L; Dearman RJ; Kimber I; Ryan CA; Gerberick GF; Harvey P; Evans P; White IR; Rycroft RJ
Contact Dermatitis; 2000 Jun; 42(6):344-8. PubMed ID: 10871098
[TBL] [Abstract][Full Text] [Related]
10. Estimation of relative skin sensitizing potency using the local lymph node assay: a comparison of formaldehyde with glutaraldehyde.
Hilton J; Dearman RJ; Harvey P; Evans P; Basketter DA; Kimber I
Am J Contact Dermat; 1998 Mar; 9(1):29-33. PubMed ID: 9471984
[TBL] [Abstract][Full Text] [Related]
11. A comparison of statistical approaches to the derivation of EC3 values from local lymph node assay dose responses.
Basketter DA; Lea LJ; Dickens A; Briggs D; Pate I; Dearman RJ; Kimber I
J Appl Toxicol; 1999; 19(4):261-6. PubMed ID: 10439340
[TBL] [Abstract][Full Text] [Related]
12. Human potency predictions for aldehydes using the local lymph node assay.
Basketter DA; Wright ZM; Warbrick EV; Dearman RJ; Kimber I; Ryan CA; Gerberick GF; White IR
Contact Dermatitis; 2001 Aug; 45(2):89-94. PubMed ID: 11553118
[TBL] [Abstract][Full Text] [Related]
13. Contact and respiratory sensitizers can be identified by cytokine profiles following inhalation exposure.
De Jong WH; Arts JH; De Klerk A; Schijf MA; Ezendam J; Kuper CF; Van Loveren H
Toxicology; 2009 Jul; 261(3):103-11. PubMed ID: 19422874
[TBL] [Abstract][Full Text] [Related]
14. Contact allergenic potency: correlation of human and local lymph node assay data.
Gerberick GF; Robinson MK; Ryan CA; Dearman RJ; Kimber I; Basketter DA; Wright Z; Marks JG
Am J Contact Dermat; 2001 Sep; 12(3):156-61. PubMed ID: 11526521
[TBL] [Abstract][Full Text] [Related]
15. Comparison of dose-responses of contact allergens using the guinea pig maximization test and the local lymph node assay.
van Och FM; Vandebriel RJ; Prinsen MK; De Jong WH; Slob W; van Loveren H
Toxicology; 2001 Oct; 167(3):207-15. PubMed ID: 11578800
[TBL] [Abstract][Full Text] [Related]
16. Utilization of the ex vivo LLNA: BrdU-ELISA to distinguish the sensitizers from irritants in respect of 3 end points-lymphocyte proliferation, ear swelling, and cytokine profiles.
Arancioglu S; Ulker OC; Karakaya A
Int J Toxicol; 2015; 34(1):24-30. PubMed ID: 25563296
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of contact sensitivity of rubber chemicals using the murine local lymph node assay.
Ikarashi Y; Tsuchiya T; Nakamura A
Contact Dermatitis; 1993 Feb; 28(2):77-80. PubMed ID: 8384542
[TBL] [Abstract][Full Text] [Related]
18. Development and utilization of an ex vivo bromodeoxyuridine local lymph node assay protocol for assessing potential chemical sensitizers.
Williams WC; Copeland C; Boykin E; Quell SJ; Lehmann DM
J Appl Toxicol; 2015 Jan; 35(1):29-40. PubMed ID: 24532485
[TBL] [Abstract][Full Text] [Related]
19. Local lymph node assay responses to paraphenylenediamine: intra- and inter-laboratory evaluations.
Warbrick EV; Dearman RJ; Lea LJ; Basketter DA; Kimber I
J Appl Toxicol; 1999; 19(4):255-60. PubMed ID: 10439339
[TBL] [Abstract][Full Text] [Related]
20. Increased cell proliferation in spleen and lymph nodes peripheral to contact allergen application site.
Chipinda I; Anderson SE; Butterworth LF; Beezhold D; Siegel PD
Toxicology; 2009 Mar; 257(3):113-6. PubMed ID: 19150643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
